Skip to content
HowShorted

Lexeo Therapeutics, Inc. short interest in 2026

In 2026, Lexeo Therapeutics, Inc.'s disclosed short interest ran from 15.70% of shares outstanding on 15 Jan 2026 to 25.14% on 15 Sep 2026, a change of +9.44 percentage points. The year's high was 25.14% on 15 Sep 2026 and its low 15.24% on 27 Feb 2026, averaging 19.30% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 33.44 days on 15 Sep 2026. Full history: Lexeo Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2024 · 2025 · 2026

Aggregate net short position time series for Lexeo Therapeutics, Inc. in 2026

2026 in figures

Start of year
15.70% (15 Jan 2026)
End of year
25.14% (15 Sep 2026)
Change
+9.44 pp
High
25.14% (15 Sep 2026)
Low
15.24% (27 Feb 2026)
Average
19.30%
Highest days to cover
33.44 (15 Sep 2026)
SEC filings marked
6

Every report in 2026

Lexeo Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202615.70%6.85
30 Jan 202616.41%14.55
13 Feb 202615.70%12.83
27 Feb 202615.24%19.05
13 Mar 202616.16%11.36
31 Mar 202616.87%14.1410-K filed, results (8-K)
15 Apr 202617.01%9.87
30 Apr 202617.63%18.92
15 May 202617.83%18.8210-Q filed, results (8-K)
29 May 202618.59%17.36
15 Jun 202619.02%18.81
30 Jun 202621.77%14.02
15 Jul 202622.07%19.55
31 Jul 202623.02%16.87
14 Aug 202624.96%19.7710-Q filed, results (8-K)
31 Aug 202624.97%26.82
15 Sep 202625.14%33.44

See also: Lexeo Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.